eli lilly oral glp 1 The Food and Drug Administration has approved the first GLP-1 weight loss drug by Lilly, called Foundayo Eli Lilly Says Oral GLP-1
Description
Archived from the original on 6 January 2024

uncommon or unconfirmed more severe reactions may include acute kidney injury, hypoglycemia, thyroid neoplasia and acute pancreatitis

These treatments can aid in weight loss, enhance insulin sensitivity, and help regulate menstrual cycles
But experts wonder how much is too much Bethany Brookshire Inside the Weight-Loss Drug Revolution: Promises, Pitfalls and a Pharma Arms Race Behind the hype of GLP-1 medications lies complex science, serious side effects and a pharmaceutical arms race

doi: 10.1056/NEJMoa2204601
